← Evidence map

ReviewOncoTargets and therapy2016

PI3K inhibitors as new cancer therapeutics: implications for clinical trial design.

Cristian Massacesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

122 papers cite itlatest 60 shown

2016
…
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26793003